Does everyone need to take vitamin D? High prevalence of CYP24A1 deficiency in the Russian population
Problems of Endocrinology · 2025
DOI: 10.14341/probl13561 ↗Kurz gefasst
Fachartikel in der Zeitschrift Problems of Endocrinology, 2025. Verfasst von K S Kulikova und 14 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Medical Genetics; Endocrinology Research Centre; Russian Children's Clinical Hospital - Pirogov Russian National Research Medical Universi…. Hauptthemen laut MEDLINE: Vitamin D3 24-Hydroxylase, Hypercalcemia, Vitamin D. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
24-hydroxylase deficiency (or infantile hypercalcemia type 1) is an inherited disease associated with biallelic loss-of-function CYP24A1 mutations lead to impaired inactivation of vitamin D metabolites and characterised hypercalcemia, nephrocalcinosis and/or urolithiasis. We present 44 patients, the largest group (n=41) consisted of children. The main complaints at the time of examination was: weight loss, refusal to eat, delayed physical and/or psychomotor development, signs of urinary tract infection and/or nephrocalcinosis (in adults — urolithiasis). Hypercalcemia was detected in 88.6%, with Me 2.9 [2.65; 4.03] mmol/L. Me of the 25(OH)D3:24.25(OH)2D3 ratio was 340.65 [132.2; 630.75] (n=10). Hypercalciuria was detected in 59%, nephrocalcinosis or urolithiasis in 95% of cases. Frequent mutations in the CYP24A1 gene were p.Arg396Trp (66%) and p.Glu143del. (27%). Incidence of 24-hydroxylase deficiency in Russian population was 1:10900 estimated on the basis of these alleles of CYP24A1 , overall carrier frequency for these mutations in CYP24A1 was 1 in 53 people. In conclusion, we propose to conduct molecular testing for the presence of pathogenic variants p.Arg396Trp and p.Glu143del in CYP24A1 during neonatal screening, due to the high expected frequency of 24-hydroxylase deficiency and heterozygous carriage of pathogenic variants of CYP24A1 in Russia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Centre for Medical Genetics; Endocrinology Research Centre; Russian Children's Clinical Hospital - Pirogov Russian National Research Medical University.
- Veltischev Research Clinical Institute for Pediatrics and Pediatric Surgery.
- Centre for Medical Genetics.
- N.F. Filatov Children City Hospital.
- Endocrinology Research Centre.
- National Medical Research Center of Children Health.
Zitieren
APA
Kulikova, K. S., Papizh, S. V., Polyakov, A. V., Marakhonov, A. V., Beskorovainiy, N. S., Shumikhina, M. V., Sozaeva, L. S., Frolova, E. B., Kalinchenko, N. Y., Yanar, E. A., Rozhinskaya, L. Y., Tikhonovich, Y. V., Bogdanov, V. P., Ioutsi, V. A., & Tyulpakov, A. N. (2025). Does everyone need to take vitamin D? High prevalence of CYP24A1 deficiency in the Russian population. Problems of Endocrinology. https://doi.org/10.14341/probl13561
Vancouver
Kulikova KS, Papizh SV, Polyakov AV, Marakhonov AV, Beskorovainiy NS, Shumikhina MV, et al. Does everyone need to take vitamin D? High prevalence of CYP24A1 deficiency in the Russian population. Problems of Endocrinology. 2025. doi:10.14341/probl13561
BibTeX
@article{Kulikova2025,
author = {Kulikova, K S and Papizh, S V and Polyakov, A V and Marakhonov, A V and Beskorovainiy, N S and Shumikhina, M V and Sozaeva, L S and Frolova, E B and Kalinchenko, N Yu and Yanar, E A and Rozhinskaya, L Ya and Tikhonovich, Yu V and Bogdanov, V P and Ioutsi, V A and Tyulpakov, A N},
title = {Does everyone need to take vitamin D? High prevalence of CYP24A1 deficiency in the Russian population},
journal = {Problems of Endocrinology},
year = {2025},
doi = {10.14341/probl13561}
}
EUVIMED